acetylcysteine has been researched along with Friedreich Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bertini, ES; D'Amico, J; La Rosa, P; Petrillo, S; Piemonte, F | 1 |
Chiang, S; Huang, MLH; Richardson, DR | 1 |
D'Autréaux, B; Martin, E; Monnier, V; Russi, M; Tixier, L; Tricoire, H | 1 |
Johnson, WM; Mieyal, JJ; Wilson-Delfosse, AL | 1 |
1 review(s) available for acetylcysteine and Friedreich Disease
Article | Year |
---|---|
Dysregulation of glutathione homeostasis in neurodegenerative diseases.
Topics: Acetylcysteine; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Brain; Friedreich Ataxia; Glutathione; Homeostasis; Humans; Huntington Disease; Neurodegenerative Diseases; Parkinson Disease | 2012 |
3 other study(ies) available for acetylcysteine and Friedreich Disease
Article | Year |
---|---|
Targeting NRF2 for the Treatment of Friedreich's Ataxia: A Comparison among Drugs.
Topics: Acetylcysteine; Biopsy; Down-Regulation; Drug Evaluation, Preclinical; Frataxin; Friedreich Ataxia; Humans; Iron-Binding Proteins; Isothiocyanates; Molecular Targeted Therapy; NF-E2-Related Factor 2; Oxidation-Reduction; Signal Transduction; Sulfoxides; Time Factors; Transcriptional Activation | 2019 |
Treatment of dilated cardiomyopathy in a mouse model of Friedreich's ataxia using N-acetylcysteine and identification of alterations in microRNA expression that could be involved in its pathogenesis.
Topics: Acetylcysteine; Animals; Basic-Leucine Zipper Transcription Factors; Cardiomyopathy, Dilated; Cell Line, Tumor; Disease Models, Animal; Frataxin; Friedreich Ataxia; Gene Expression Regulation; Humans; Iron-Binding Proteins; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Mice, Knockout; MicroRNAs; Myocytes, Cardiac; NF-E2-Related Factor 2; Sulfoxides | 2020 |
A Drosophila model of Friedreich ataxia with CRISPR/Cas9 insertion of GAA repeats in the frataxin gene reveals in vivo protection by N-acetyl cysteine.
Topics: Acetylcysteine; Animals; CRISPR-Cas Systems; Disease Models, Animal; Drosophila melanogaster; Frataxin; Friedreich Ataxia; Humans; Introns; Iron-Binding Proteins; Oxidative Stress; RNA-Seq; Trinucleotide Repeat Expansion | 2020 |